Measuring Particle Size Distribution by Asymmetric Flow Field Flow Fractionation: A Powerful Method for the Preclinical Characterization of Lipid-Based Nanoparticles-Reference-Cited by-同舟云学术

Measuring Particle Size Distribution by Asymmetric Flow Field Flow Fractionation: A Powerful Method for the Preclinical Characterization of Lipid-Based Nanoparticles

Published:2019-01-03 Issue:2 Volume:16 Page:756-767
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Caputo Fanny¹^ORCID,Arnould Amandine²,Bacia Maria³,Ling Wai Li³^ORCID,Rustique Emilie¹,Texier Isabelle¹,Mello Adriele Prina⁴⁵,Couffin Anne-Claude¹

Affiliation:

1. Univ. Grenoble Alpes, CEA, LETI, F-38000 Grenoble, France

2. Univ. Grenoble Alpes, CEA, LITEN, F-38000 Grenoble, France

3. Univ. Grenoble Alpes, CEA, CNRS, IBS, F-38000 Grenoble, France

4. Laboratory for Biological Characterisation of Advanced Materials (LBCAM), Department of Clinical Medicine, Trinity Translational Medicine Institute (TTMI), School of Medicine, Trinity College Dublin, Dublin 8, Ireland

5. AMBER Centre and CRANN Institute, Trinity College Dublin, Dublin 2, Ireland

Funder

H2020 Research Infrastructures

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

http://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.8b01033

Reference44 articles.

1. The evolving landscape of drug products containing nanomaterials in the United States

2. Characterization of nanomedicines: A reflection on a field under construction needed for clinical translation success